Sathekge, Mike Machaba; Warwick, J.M.; Doruyter, A.; Vorster, Mariza(Health and Medical Publishing Group, 2015-11)
Individualised patient treatment approaches demand precise determination of initial disease extent combined with early, accurate
assessment of response to treatment, which is made possible by positron emission tomography/computed ...
Vorster, Mariza; Doruyter, A.; Brink, A.; Mkhize, S.; Holness, J.; Malan, N.; Nyakale, Nozipho E.; Warwick, J.M.; Sathekge, Mike Machaba(Health and Medical Publishing Group, 2016-01)
These recommendations are intended to serve an important and relevant role in advising referring physicians on the appropriate use
of 18F-fluorodeoxyglucose (18F-FDG) and non-18F-FDG positron emission tomography/computed ...
Warwick, J.M.; Sathekge, Mike Machaba(Elsevier, 2011-04)
Positron emission tomography (PET) with [F-18]-fluoro-deoxy-glucose (FDG) has a well
established and growing role in the management of most lymphomas. The interpretation
of FDG PET scans in HIV positive patients is however ...
